ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 267 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $594 | -24.6% | 22,100 | 0.0% | 0.02% | -28.6% |
Q2 2023 | $788 | +61.5% | 22,100 | +15.1% | 0.04% | +40.0% |
Q1 2023 | $488 | -27.5% | 19,200 | +15.7% | 0.02% | -30.6% |
Q4 2022 | $673 | -99.9% | 16,600 | 0.0% | 0.04% | +20.0% |
Q3 2022 | $549,000 | -6.0% | 16,600 | 0.0% | 0.03% | +7.1% |
Q2 2022 | $584,000 | -41.0% | 16,600 | -22.8% | 0.03% | -24.3% |
Q1 2022 | $989,000 | -30.6% | 21,500 | 0.0% | 0.04% | -22.9% |
Q4 2021 | $1,425,000 | +6.2% | 21,500 | 0.0% | 0.05% | +2.1% |
Q3 2021 | $1,342,000 | -24.6% | 21,500 | 0.0% | 0.05% | -23.0% |
Q2 2021 | $1,781,000 | +50.0% | 21,500 | +20.1% | 0.06% | +29.8% |
Q1 2021 | $1,187,000 | -13.5% | 17,900 | 0.0% | 0.05% | -19.0% |
Q4 2020 | $1,373,000 | +52.6% | 17,900 | -14.4% | 0.06% | +38.1% |
Q3 2020 | $900,000 | -12.5% | 20,900 | -12.2% | 0.04% | -14.3% |
Q2 2020 | $1,028,000 | +50.1% | 23,800 | 0.0% | 0.05% | +19.5% |
Q1 2020 | $685,000 | -37.6% | 23,800 | +37.6% | 0.04% | -10.9% |
Q4 2019 | $1,097,000 | – | 17,300 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |